Bristol's CheckMate 067 Revives Debate On Rationing Yervoy/Opdivo Combo

Yervoy/Opdivo combo proves significant survival benefit over Yervoy alone in Phase III frontline melanoma study, but is on par with Opdivo alone in patients with higher PD-L1 expression.